129 related articles for article (PubMed ID: 2277302)
1. Prostacyclin in the management of pulmonary hypertension after heart transplantation.
Pascual JM; Fiorelli AI; Bellotti GM; Stolf NA; Jatene AD
J Heart Transplant; 1990; 9(6):644-51. PubMed ID: 2277302
[TBL] [Abstract][Full Text] [Related]
2. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
3. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E1 infusion for right ventricular failure after cardiac transplantation.
Vincent JL; Carlier E; Pinsky MR; Goldstein J; Naeije R; Lejeune P; Brimioulle S; Leclerc JL; Kahn RJ; Primo G
J Thorac Cardiovasc Surg; 1992 Jan; 103(1):33-9. PubMed ID: 1728711
[TBL] [Abstract][Full Text] [Related]
5. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
6. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary vasodilation after heart transplantation. A comparison among prostacyclin, sodium nitroprusside, and nitroglycerin on right ventricular function and pulmonary selectivity.
Kieler-Jensen N; Milocco I; Ricksten SE
J Heart Lung Transplant; 1993; 12(2):179-84. PubMed ID: 8476888
[TBL] [Abstract][Full Text] [Related]
8. [Short-term survival after heart transplantation: the relationships between preoperative hemodynamics, organ function and postoperative clinical events].
Frigerio M; Gronda E; Danzi GB; Mangiavacchi M; Oliva F; Quaini E; Trotta E; De Vita C; Pellegrini A
G Ital Cardiol; 1995 Jan; 25(1):1-9. PubMed ID: 7642005
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
[TBL] [Abstract][Full Text] [Related]
10. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation.
Bourge RC; Kirklin JK; Naftel DC; White C; Mason DA; Epstein AE
J Thorac Cardiovasc Surg; 1991 Mar; 101(3):432-44; discussion 444-5. PubMed ID: 1999936
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function.
Van der Linden P; Le Moine O; Ghysels M; Ortinez M; Devière J
Hepatology; 1996 May; 23(5):982-7. PubMed ID: 8621179
[TBL] [Abstract][Full Text] [Related]
12. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
[TBL] [Abstract][Full Text] [Related]
13. The early course of pulmonary artery hypertension in patients undergoing mitral valve replacement with cardioplegic arrest.
Foltz BD; Hessel EA; Ivey TD
J Thorac Cardiovasc Surg; 1984 Aug; 88(2):238-47. PubMed ID: 6748718
[TBL] [Abstract][Full Text] [Related]
14. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation].
Liu MZ; Wang JH; Du J; Huang J; Li LH
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2618-22. PubMed ID: 18162149
[TBL] [Abstract][Full Text] [Related]
15. Low doses of inhaled nitric oxide in heart transplant recipients.
Auler Júnior JO; Carmona MJ; Bocchi EA; Bacal F; Fiorelli AI; Stolf NA; Jatene AD
J Heart Lung Transplant; 1996 May; 15(5):443-50. PubMed ID: 8771498
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic reduction of pretransplantation pulmonary vascular resistance predicts outcome after pediatric heart transplantation.
Zales VR; Pahl E; Backer CL; Crawford S; Mavroudis C; Benson DW
J Heart Lung Transplant; 1993; 12(6 Pt 1):965-72; discussion 972-3. PubMed ID: 8312321
[TBL] [Abstract][Full Text] [Related]
17. [Hemodynamic characteristics of heart transplant patients in the early postoperative period].
Dammenhayn L; Haverich A; Coppola R; Albes J; Cremer J; Schäfers HJ; Wahlers T
Z Kardiol; 1991 Nov; 80(11):681-6. PubMed ID: 1792810
[TBL] [Abstract][Full Text] [Related]
18. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
Botha P; Parry G; Dark JH; Macgowan GA
J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
[TBL] [Abstract][Full Text] [Related]
20. The effect of low-dose intravenous nitroglycerin on pulmonary hypertension immediately after replacement of a stenotic mitral valve.
Ziskind Z; Pohoryles L; Mohr R; Smolinsky A; Quang HT; Ruvolo G; Goor DA
Circulation; 1985 Sep; 72(3 Pt 2):II164-9. PubMed ID: 3928188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
